Home » Living Safer: Has Zantac Harmed Public Health? The Alleged Connection Between Ranitidine and Cancer
Living Safer: Has Zantac Harmed Public Health? The Alleged Connection Between Ranitidine and Cancer
We are pleased to announce that the latest issue of Living Safer, your magazine for all things related to safety, is available. Please consider reading our cover story titled:
“After Decades of Use, How Much has Zantac Harmed Public Health?”
Written by Managing Partner Eric Chaffin and Partner Roopal Luhana, the article — published prior to the FDA withdrawal of all Zantac/ranitidine medications — covers important national litigation involving the link between N-Nitrosodimethylamine (NDMA), a known carcinogen, and the popular heartburn medication Zantac, and its generic form ranitidine.
If you’d like to receive future e-releases of our Living Safer Magazine, please complete the form below.
Recent Posts
- Lawsuit Filed Against Goals Plastic Surgery Clinic for Sexual Exploitation of Patient
- Chaffin Luhana LLP Furthers Growth with Expansion to Connecticut, Upholding Their Mission of ‘Doing Good by Doing Rightâ„¢’
- Uber Sexual Assault Crisis: Historic Litigation Picks Up Steam As Survivors File Master Long-Form Complaint In The Uber Passenger Sexual Assault Multi-District Litigation
- Chaffin Luhana Bolsters Team with Promotions and New Leadership Roles, Marking Milestone Growth
- Chaffin Luhana Partner, Roopal Luhana Appointed as Co-Lead In Uber Passenger Sexual Assault Litigation